Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Apr-24 5:33 PM View:  | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 05-Apr-24 | Option Exercise | 17,847 | $0.00 | $3.57 | 4% 487.46K to 505.31K | |
| 04-Mar-24 11:07 AM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 20-Sep-23 | Option Exercise | 20,728 | $0.00 | $13.92 | 4% 466.73K to 487.46K | |
| 14-Mar-23 5:04 PM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 10-Mar-23 | Option Exercise | 316,410 | $0.00 | $522.68 | 210% 150.32K to 466.73K | |
| 16-Aug-21 4:21 PM View: | Ai Eti LLC 10% Owner | Eliem Therapeutics, Inc. (ELYM) | 12-Aug-21 | Conversion | 4,209,400 | -- | -- | 100% 0 to 4.21M | |
| 16-Aug-21 4:21 PM View: | Ai Eti LLC 10% Owner | Eliem Therapeutics, Inc. (ELYM) | 12-Aug-21 | Purchase | 800,000 | $12.50 | $10,000,000.00 | 19% 4.21M to 5.01M |
